Converting enzyme inhibition: dissociation between antihypertensive and arterial effects.

In this study the dose-response curves reflecting the arterial and the antihypertensive effects of converting enzyme inhibition were analysed. The BP measurement (using a random zero sphygmomanometer) and its decrease following converting enzyme inhibition were used as a marker of the arteriolar effect of the drug. The effect on conduit arteries was evaluated through determination of carotid-femoral pulse wave velocity used as an index of arterial distensibility. We compared the dose-response curves of these two parameters in a double-blind study carried out in 24 patients with essential hypertension, who were randomised between placebo and 2, 4 and 8 mg of the converting enzyme inhibitor trandolapril given for 8 days. The antihypertensive effect was observed from 2 mg, at which dose the plateau of BP reduction was already achieved. No significant correlation was found between dose and BP reduction (r = -0.34), whereas the dose was significantly related to the change in pulse wave velocity (r = -0.56, P < 0.01). No significant correlation was found between changes in BP and change of pulse wave velocity. The study provides evidence that the effect on the conduit artery was obtained for higher doses than the BP effect in patients treated for hypertension by the converting enzyme inhibitor trandolapril.

[1]  M. Safar,et al.  Vascular effects of intravenous infusion of the angiotensin converting enzyme inhibitor perindoprilat. , 1990, Journal of hypertension.

[2]  M. Safar,et al.  Reversion of cardiac hypertrophy and reduced arterial compliance after converting enzyme inhibition in essential hypertension. , 1988, Circulation.

[3]  M. Safar,et al.  Effects of chronic inhibition of converting enzyme on mechanical and structural properties of arteries in rat renovascular hypertension. , 1988, Circulation research.

[4]  M E Safar,et al.  Large conduit arteries in hypertension: role of the vascular renin-angiotensin system. , 1988, Circulation.

[5]  M. Safar,et al.  Comparative Effects of Captopril and Isosorbide Dinitrate on the Arterial Wall of Hypertensive Human Brachial Arteries , 1986, Journal of cardiovascular pharmacology.

[6]  A. Simon,et al.  Haemodynamic effects of vasodilating drugs on the common carotid and brachial circulations of patients with essential hypertension. , 1986, British journal of clinical pharmacology.

[7]  A. Simon,et al.  Captopril-induced changes in large arteries in essential hypertension. , 1984, The American journal of medicine.

[8]  J. Levenson,et al.  Comparison of oral MK 421 and propranolol in mild to moderate essential hypertension and their effects on arterial and venous vessels of the forearm. , 1984, The American journal of cardiology.

[9]  M. Bond,et al.  Pulse wave velocity and morphological changes associated with early atherosclerosis progression in the aortas of cynomolgus monkeys. , 1984, Cardiovascular research.

[10]  A. Simon,et al.  Peripheral large arteries and the response to antihypertensive treatment. , 1983, Hypertension.

[11]  S. Textor,et al.  Antihypertensive effects of MK-421: Hemodynamic and humoral correlates , 1982 .

[12]  R. Cody,et al.  Hemodynamic and Volume Changes Associated with Captopril , 1980, Hypertension.

[13]  F. James Rohlf,et al.  Biometry: The Principles and Practice of Statistics in Biological Research , 1969 .

[14]  A. Hill,et al.  The Velocity of the Pulse Wave in Man , 1922 .